|
Jul 29
|
AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
|
|
Jun 24
|
Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?
|
|
May 22
|
Industry Analysts Just Upgraded Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts By 16%
|
|
May 9
|
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 9
|
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
|
|
May 9
|
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
|
|
May 9
|
Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties
|
|
May 2
|
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
May 1
|
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
|
|
Apr 24
|
Actym Therapeutics Appoints Thomas Smart as CEO
|
|
Apr 15
|
BTIG Research Predicts Over 118% Rally for These 3 Stocks
|
|
Apr 12
|
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
|
|
Apr 9
|
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
|
|
Mar 18
|
Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
|
|
Mar 14
|
What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
|
|
Mar 14
|
Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade
|
|
Mar 14
|
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 11
|
AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 11
|
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
|
Feb 29
|
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
|